In a SDH-linked paraganglioma tumor, which component of the electron transport chain is defective?

In a SDH-linked paraganglioma tumor, which component of the electron transport chain is defective?

• A. Complex I
• B. Complex II
• C. Complex III
• D. Complex IV

Answer: (B)

In the context of a SDH-linked paraganglioma tumor, the defect is associated with Complex II of the electron transport chain, which is also known as succinate dehydrogenase (SDH). This enzyme plays a dual role; it is a component of both the citric acid cycle (Krebs cycle) and the electron transport chain. Succinate dehydrogenase catalyzes the conversion of succinate to fumarate while reducing ubiquinone to ubiquinol in the process. In cases where there is a mutation or dysfunction in the genes encoding the SDH enzyme complex, there can be an accumulation of succinate. Elevated levels of succinate can lead to the activation of oncogenic pathways, contributing to tumorigenesis. Understanding the location of SDH within the electron transport chain is crucial because it highlights the biochemical repercussions of a malfunctioning enzyme. In paragangliomas and similar tumors, the direct impact is on energy production and cellular signaling pathways, linking the defect to the tumorigenic process. This also explains why alterations in SDH activity are specifically relevant to certain tumors, including paragangliomas and pheochromocytomas.

In the context of a SDH-linked paraganglioma tumor, the defect is associated with Complex II of the electron transport chain, which is also known as succinate dehydrogenase (SDH). This enzyme plays a dual role; it is a component of both the citric acid cycle (Krebs cycle) and the electron transport chain.

Succinate dehydrogenase catalyzes the conversion of succinate to fumarate while reducing ubiquinone to ubiquinol in the process. In cases where there is a mutation or dysfunction in the genes encoding the SDH enzyme complex, there can be an accumulation of succinate. Elevated levels of succinate can lead to the activation of oncogenic pathways, contributing to tumorigenesis.

Understanding the location of SDH within the electron transport chain is crucial because it highlights the biochemical repercussions of a malfunctioning enzyme. In paragangliomas and similar tumors, the direct impact is on energy production and cellular signaling pathways, linking the defect to the tumorigenic process. This also explains why alterations in SDH activity are specifically relevant to certain tumors, including paragangliomas and pheochromocytomas.